Professional overview
Dr. Li Yanping is a Chief Physician and Director of the Breast Surgery Department at Beijing Shijitan Hospital, specializing in the diagnosis and treatment of breast diseases.
Department leadership
A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.
Areas of focus
Background
- 2008Principal Investigator of a Ministry of Health-funded project on clinical application of fluorescence in situ hybridization (FISH) for HER-2/neu gene amplification detection in breast cancer.
- 2010Co-investigator of a National Natural Science Foundation of China (NSFC) project on tripterygium toxicity-efficacy correlation mediated by estrogen receptor.
- 2013–2015Co-investigator of a Beijing Municipal Science and Technology Commission project on ER pathway-based herbal formula reversing endocrine therapy resistance in breast cancer.
- 2015–2018Major participant in a clinical study on selective Treg inhibition combined with endocrine therapy for elderly metastatic breast cancer patients intolerant to or failing chemotherapy.
- 2018–2021Co-investigator of a 'Capital Clinical Characteristic Application Research' project on PD-1/PD-L1 expression in peripheral blood of breast cancer patients.
- 2019–2020PI of a multicenter, randomized, double-blind, parallel-controlled Phase III trial comparing trastuzumab deruxtecan plus docetaxel versus trastuzumab plus docetaxel in patients with HER2-overexpressing metastatic breast cancer.
- 2020–2021PI of a Phase I clinical study evaluating the safety and tolerability of SHR-A1201 in patients with HER2-positive advanced breast cancer.
- 2020–2021PI of a randomized Phase III trial comparing entinostat versus placebo combined with endocrine therapy in patients with hormone receptor-positive advanced breast cancer.
- 2021Principal Investigator (PI) of a multicenter, randomized, open-label, single-dose, two-cycle, crossover bioequivalence trial of liposomal doxorubicin hydrochloride in female patients with breast cancer.
Experience & recognition
- Completed nearly 10,000 breast cancer radical surgeries
- Editor-in-chief of 'Training Manual for Early Breast Cancer Screening' (China Women's Development Foundation, 2014)
- Co-editor of the humanistic book 'You Are Not Alone' (published overseas in 2024)
- Recipient of the 'Anti-Cancer Guardian' award (2017, Breast Cancer Lehuozhe Alliance)
- Recipient of hospital-level awards for innovation in sentinel lymph node biopsy and wire localization biopsy (2011, 2013)
- Recipient of hospital-level awards for mammary ductoscopy-assisted foreign body removal (2011) and mammary ductoscopy application in nipple discharge (2012)
- Recipient of the Liaoning Provincial Science and Technology Progress Third Prize for research on biological prognostic indicators in lymph node-negative breast cancer
Professional roles
- Member, Breast Cancer Prevention and Control Expert Committee, Women's Health Promotion Special Fund, China Health Promotion Foundation
- Vice Chair, Health Management Professional Committee, Beijing Society for Breast Disease Prevention and Treatment
- Vice Chair, Mass Work Committee, Beijing Society for Breast Disease Prevention and Treatment
- Vice Chair, National Expert Committee on Breast Cancer Integration, Beijing Association for Promoting Integrated Traditional Chinese and Western Medicine for Chronic Disease Prevention and Control
- Standing Committee Member, Palliative Care Professional Committee, Beijing Oncology Society
- Standing Committee Member, National Expert Committee on Breast Cancer Prevention and Control, Beijing Association for Promoting Integrated Traditional Chinese and Western Medicine for Chronic Disease Prevention and Control
- Standing Committee Member, Surgical Professional Committee, Beijing Society for Breast Disease Prevention and Treatment
- Standing Committee Member, Translational Medicine Professional Committee, Beijing Society for Breast Disease Prevention and Treatment
Frequently asked questions
What does Dr. Li Yanping specialize in?
Specializes in breast-conserving surgery, modified radical mastectomy, sentinel lymph node biopsy, and comprehensive treatment including neoadjuvant, adjuvant, endocrine, and targeted therapy; also performs minimally invasive treatment for benign breast tumors, especially for non-palpable suspicious malignant lesions using ultrasound- or mammography-guided wire localization.
Which hospital and department is Dr. Li Yanping in?
Breast Surgery Department at Beijing Shijitan Hospital
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Li Yanping has not reviewed this page. Request a correction or removal.
